Beyond PD-L1: B7-H6 emerges as a potential immunotherapy target in small cell lung cancer. Thomas PL, Groves SM, Zhang YK, Li J, et al. J Thorac Oncol 2021 Apr 8. pii: S1556-0864(21)02066.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Thomas PL, Groves SM, Zhang YK, Li J, et al. Beyond PD-L1: B7-H6 emerges as a potential immunotherapy target in small cell lung cancer. J Thorac Oncol 2021 Apr 8. pii: S1556-0864(21)02066.
PMID: 33839362